Cargando…

Oral contraceptives and hypertension in women: results of the enrolment phase of Tabari Cohort Study

BACKGROUND: The association between oral contraceptives (OCP) and hypertension has been reported in the literature with controversial results. According to the growing use of OCPs among women in Iran, this study aims to investigate the association between the duration of the OCP consumption and risk...

Descripción completa

Detalles Bibliográficos
Autores principales: Afshari, Mahdi, Alizadeh-Navaei, Reza, Moosazadeh, Mahmood
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161571/
https://www.ncbi.nlm.nih.gov/pubmed/34049551
http://dx.doi.org/10.1186/s12905-021-01376-4
_version_ 1783700536795594752
author Afshari, Mahdi
Alizadeh-Navaei, Reza
Moosazadeh, Mahmood
author_facet Afshari, Mahdi
Alizadeh-Navaei, Reza
Moosazadeh, Mahmood
author_sort Afshari, Mahdi
collection PubMed
description BACKGROUND: The association between oral contraceptives (OCP) and hypertension has been reported in the literature with controversial results. According to the growing use of OCPs among women in Iran, this study aims to investigate the association between the duration of the OCP consumption and risk of hypertension among Iranian women. METHODS: In the current study, the data collected during the enrolment phase of the Tabari cohort were analyzed. Of 6106 women recruited in the cohort, 133 pregnant women were excluded. Epidemiological variables were collected using pre-designed questionnaires as well as the health insurance evidences. In addition, blood pressure and anthropometric factors were measured based on the standard guidelines. Chi square and partial correlation tests as well as logistic regression models were applied for data analysis. RESULTS: Frequency of oral contraceptive use among 35–70 year-old women in Tabari cohort study (TCS) was 42.2% (2520/5973). Hypertension was observed among 25% (1793/5973) of them. The adjusted odds ratio for OCP use was 1.23 (95% confidence interval: 1.08, 1.40, p = 0.002). The corresponding odds ratios for 61–120 months and more than 120 months OCP use were 1.39 (1.12,1.73) and 1.47 (1.16,1.87) respectively. CONCLUSIONS: Oral contraceptives especially in long term use can be associated with hypertension.
format Online
Article
Text
id pubmed-8161571
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81615712021-06-01 Oral contraceptives and hypertension in women: results of the enrolment phase of Tabari Cohort Study Afshari, Mahdi Alizadeh-Navaei, Reza Moosazadeh, Mahmood BMC Womens Health Research BACKGROUND: The association between oral contraceptives (OCP) and hypertension has been reported in the literature with controversial results. According to the growing use of OCPs among women in Iran, this study aims to investigate the association between the duration of the OCP consumption and risk of hypertension among Iranian women. METHODS: In the current study, the data collected during the enrolment phase of the Tabari cohort were analyzed. Of 6106 women recruited in the cohort, 133 pregnant women were excluded. Epidemiological variables were collected using pre-designed questionnaires as well as the health insurance evidences. In addition, blood pressure and anthropometric factors were measured based on the standard guidelines. Chi square and partial correlation tests as well as logistic regression models were applied for data analysis. RESULTS: Frequency of oral contraceptive use among 35–70 year-old women in Tabari cohort study (TCS) was 42.2% (2520/5973). Hypertension was observed among 25% (1793/5973) of them. The adjusted odds ratio for OCP use was 1.23 (95% confidence interval: 1.08, 1.40, p = 0.002). The corresponding odds ratios for 61–120 months and more than 120 months OCP use were 1.39 (1.12,1.73) and 1.47 (1.16,1.87) respectively. CONCLUSIONS: Oral contraceptives especially in long term use can be associated with hypertension. BioMed Central 2021-05-28 /pmc/articles/PMC8161571/ /pubmed/34049551 http://dx.doi.org/10.1186/s12905-021-01376-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Afshari, Mahdi
Alizadeh-Navaei, Reza
Moosazadeh, Mahmood
Oral contraceptives and hypertension in women: results of the enrolment phase of Tabari Cohort Study
title Oral contraceptives and hypertension in women: results of the enrolment phase of Tabari Cohort Study
title_full Oral contraceptives and hypertension in women: results of the enrolment phase of Tabari Cohort Study
title_fullStr Oral contraceptives and hypertension in women: results of the enrolment phase of Tabari Cohort Study
title_full_unstemmed Oral contraceptives and hypertension in women: results of the enrolment phase of Tabari Cohort Study
title_short Oral contraceptives and hypertension in women: results of the enrolment phase of Tabari Cohort Study
title_sort oral contraceptives and hypertension in women: results of the enrolment phase of tabari cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8161571/
https://www.ncbi.nlm.nih.gov/pubmed/34049551
http://dx.doi.org/10.1186/s12905-021-01376-4
work_keys_str_mv AT afsharimahdi oralcontraceptivesandhypertensioninwomenresultsoftheenrolmentphaseoftabaricohortstudy
AT alizadehnavaeireza oralcontraceptivesandhypertensioninwomenresultsoftheenrolmentphaseoftabaricohortstudy
AT moosazadehmahmood oralcontraceptivesandhypertensioninwomenresultsoftheenrolmentphaseoftabaricohortstudy